Internal Medicine, Interventional Cardiology · Ocala, FL
NPI
1063448488
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2105 SW 20th Pl
Ocala, FL, 34471
Phone (352) 622-4251
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
18,584 services
Medicare patients, 2024
2,010
Average age 77
Drug cost, 2024
$2.5M
9,482 prescriptions
Company payments, 2025
$5,327
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Siva S Gummadi was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 2,960 times for 51 patients. In total Siva S Gummadi billed 18,584 services in 89 codes, and Medicare paid $2.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-03-17.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,960 | 51 | $0.10 | $304 |
| 99214 Office E&M - Established | Office | 2,358 | 1,189 | $96.65 | $228K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,256 | 314 | $5.19 | $6,520 |
| 93306 Echocardiography (TTE/TEE) | Office | 818 | 788 | $88.51 | $72K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 584 | 292 | $338.70 | $198K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 473 | 466 | $46.41 | $22K |
| 93296 External Electrocardiographic Monitoring | Office | 449 | 145 | $15.89 | $7,136 |
| 93000 Electrocardiogram | Office | 400 | 388 | $10.63 | $4,252 |
| 93297 External Electrocardiographic Monitoring | Office | 388 | 64 | $45.69 | $18K |
| 93298 External Electrocardiographic Monitoring | Office | 382 | 60 | $78.18 | $30K |
| 93015 Electrocardiogram | Office | 319 | 319 | $58.37 | $19K |
| 93294 External Electrocardiographic Monitoring | Office | 295 | 99 | $22.60 | $6,666 |
| 78434 Myocardial Perfusion Scan | Office | 292 | 292 | $477.16 | $139K |
| 78431 Myocardial Perfusion Scan | Office | 292 | 292 | $1,891.32 | $552K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 284 | 268 | $13.72 | $3,897 |
By year: 2022 $1.8M for 16,271 services; 2023 $1.9M for 16,027 services; 2024 $2.0M for 18,584 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 163 | 13 | $4.20 | $685 |
Medicare prescription drug claims, 2024
In 2024, the drug Siva S Gummadi prescribed most often to Medicare patients was Eliquis (Apixaban), with 794 prescriptions and refills. In total Siva S Gummadi wrote 9,482 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 794 | 1,715 | 221 | $971K |
| Clopidogrel Clopidogrel Bisulfate | 686 | 1,662 | 318 | $6,971 |
| Amlodipine Besylate Generic | 597 | 1,688 | 202 | $3,431 |
| Metoprolol Succinate Generic | 582 | 1,654 | 188 | $11K |
| Metoprolol Tartrate Generic | 553 | 1,576 | 194 | $4,085 |
| Atorvastatin Calcium Generic | 519 | 1,453 | 176 | $5,525 |
| Entresto Sacubitril/Valsartan | 494 | 1,033 | 131 | $657K |
| Losartan Potassium Generic | 463 | 1,340 | 165 | $3,810 |
| Carvedilol Generic | 388 | 1,128 | 132 | $3,727 |
| Sotalol Sotalol Hcl | 334 | 958 | 111 | $11K |
| Potassium Chloride Generic | 298 | 609 | 105 | $3,141 |
| Rosuvastatin Calcium Generic | 262 | 679 | 95 | $2,945 |
| Xarelto Rivaroxaban | 244 | 471 | 66 | $255K |
| Furosemide Generic | 229 | 524 | 97 | $1,057 |
| Lisinopril Generic | 223 | 648 | 75 | $1,793 |
Brand drugs: - claims; generic drugs: 7,451 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Siva S Gummadi $5,327 ($5,327 in general payments such as food, travel and fees) from 20 companies. The largest payer was Ge Healthcare with $3,324.
| Company | Payments | Amount |
|---|---|---|
| Ge Healthcare GEHC | 2 | $3,324 |
| Pfizer Inc. PFE | 14 | $273 |
| Philips North America LLC PHG | 18 | $261 |
| AngioDynamics, Inc. ANGO | 13 | $242 |
| Cook Medical LLC | 12 | $204 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $173 |
| Amgen Inc. AMGN | 9 | $145 |
| Kestra Medical Technology Services, Inc. | 8 | $143 |
| Boston Scientific Corporation BSX | 4 | $109 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $81.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.